PURCHASE, NY. — Recognizing that there will be broader adoption of GLP-1 medications for weight loss as the drugs become more affordable and convenient, Ramon Laguarta, chief executive officer of ...
Recognizing that there will be broader adoption of GLP-1 medications for weight loss as the drugs become more affordable and convenient, Ramon Laguarta, chief executive officer of PepsiCo, Inc., said ...
Driven by accelerating demand from semiconductors, lithium-ion batteries, pharmaceuticals, and petrochemicals, the global N-Methyl-2-pyrrolidone (NMP) market is set to nearly double in value by 2031.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results